Abu Dhabi is set to host the Middle East’s first-of-its-kind conference and exhibition dedicated to longevity science, biotechnology, regenerative medicine, ultra-personalised wellness, and AI-powered healthcare innovation, Revive ME. Taking place on 26 – 27 November 2025 at Beach Rotana, Abu Dhabi, this transformative event will bring together global pioneers, scientific leaders, and healthcare futurists, positioning the UAE capital as an emerging global hub for the longevity and healthtech revolution.
DRUID AI announced it has secured $31 million in Series C financing to advance the global expansion of its enterprise-ready agentic AI platform under the leadership of its new CEO, Joseph Kim. The strategic investment, which will advance DRUID AI’s mission to empower companies to create, manage, and orchestrate conversational AI agents, was led by Cipio Partners, with participation from TQ Ventures, Karma Ventures, Smedvig, and Hoxton Ventures.
Duel, the leading Brand Advocacy platform helping leading retail brands including Lush, ELEMIS, Victoria’s Secret and Abercrombie & Fitch grow through their own fan and creator communities instead of traditional advertising, has raised $16 million in a Series A round. The funding was co-led by Molten Ventures and Bright Pixel, alongside existing investor Peter Bauer, founder of Mimecast.
Dutch foodtech scale-up Revyve has raised nearly €24 million in Series B financing, bringing its total capital raised to more than €40 million. The investment will accelerate the company’s commercial rollout of functional yeast proteins designed to replace eggs and additives in mainstream food categories.
Nick Perrett spent years building gaming mechanics before losing track of his own pensions – an expensive wake-up call that led him to found Prosper. His contrarian view: ethical fintech isn’t just morally right, it’s more profitable long-term – and founders who understand this will build the next generation of financial giants.
Scindo, a UK-based startup developing a data-rich AI platform to discover and design next-generation enzymes, has raised £4 million in funding co-led by Kadmos Capital and Clay Capital, with participation from PINC, the venture arm of international food and beverage company Paulig, and existing investors Synbioven, AgFunder, SOSV, Farvatn Venture and Savantus Ventures. The investment will accelerate Scindo’s mission to enable bio-based ingredients and sustainable chemistry across multiple high-value sectors.













